Arkolith/Insider Trading/NAMS/Form 4

Topper James N

DirectorNewAmsterdam Pharma Co N.V. (NAMS) · full profile →Form 4 · filed Sep 17, 2025
Net Buying
Open-Market Buys
$16K
Open-Market Sells
$0
Net Open-Market Flow
$16K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2025Buy(P)660$23.70$16K3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001341382-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML